Page 16 - Lobe Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Psilocybin Patent Race Is On It feels like these companies are casting a wide net, but it makes sense to file at the beginning of this mushroom mania. Mar 06, 2021 | 12:30 PM EST It seems that a week doesn't go by without a psychedelic company saying it has filed for a patent of some sort. This process can be confusing as the first assumption is that these companies are trying to patent a natural product. It isn't difficult to see how this misunderstanding happens. The headlines shout psychedelic company! Psilocybin! Patent! That, however, isn't exactly what is happening. Truth Be...

The transaction value of approximately $32,000,000 will significantly improve Lobe's balance sheet with non-dilutive capital and will provide immediate shareholder value Vancouver, British Columbia--(Newsfile

IONIC Brands Corp.: Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp. VANCOUVER, BC / ACCESSWIRE / February 23, 2021 / Lobe Sciences Ltd. (" Lobe" or the " Company") (LOBE) and Ionic Brands Corp. (" Ionic") (CSE:IONC)(FRA:IB3)(OTC PINK:IONKD) are pleased to announce that, further to their press releases dated December 1, 2020, Lobe's wholly owned subsidiary Green Star Biosciences Inc. has signed a definitive binding asset purchase agreement dated February 22, 2021 (the " Agreement") with Ionic Brands with respect to the sale to Ionic Brands of ...

Lobe Sciences Ltd.: Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (" Lobe" or the " Company") announced today the completion and testing of the proof-of-concept prototype of its proprietary nasal mist device. As announced on December 3, 2020, the Company engaged VisionWorks Engineering of San Diego, CA to complete this first phase of development. Lobe's nasal mist device delivers "micro doses" of pharmaceutical agents such as a psilocyb...

Small Caps Daily: SmallCapsDaily: Lobe Sciences is a Major Opportunity In the Psychedelics Medicine Industry New York, New York--(Newsfile Corp. - February 12, 2021) - Lobe Sciences Ltd., (OTC Pink: GTSIF), a growth-oriented research, technology & services company that provides financial, management, IP and branding support to businesses, which focuses on the development of psilocybin-based therapeutics for mental health applications, was recently the focus of coverage by leading financial news website and publisher, SmallCapsDaily. Lobe Sciences is carving out a significant space in the bur...